The study, published in the journal Geographica Helvetica by geographers Frank I. Müller, Frank Meyer, and Judith Miggelbrink, is among the first to move beyond the textual analysis of alternative-protein hype and examine how promises about cultured meat are organised audio-visually. Drawing on Bruno Latour’s concept of translation from actor–network theory, the authors argue that promotional videos do not simply transmit information about a technology. Instead, they align heterogeneous elements, including cells, laboratories, animals, kitchens, investors, and crisis imagery, into coherent stories that reshape how each of those elements is understood. In Latourian terms, translation is not mere communication but a transformation: to translate is to link agents in ways that change them, and the videos, the researchers contend, turn laboratories into scalable futures, cells into commodities, and viewers into potential supporters or investors.

The corpus was assembled from the company database of the Good Food Institute, a non-profit that promotes animal-protein alternatives. The researchers selected short-form, English-, German-, Spanish-, or Portuguese-language videos intended to advertise companies to consumers or investors, excluding interviews and slide presentations in favour of genuine narrative storytelling. Each video was analysed as a single audio-visual unit through a two-stage coding process. The first stage coded material against four analytical entry points derived from the literature on promissory narratives: strategic positioning, material referents, temporal projection, and broader promissory framings linking crisis, ethics, and transformation. The second stage compared the coded material across the corpus to identify recurring narrative configurations. The result was six cross-cutting patterns, which the authors interpret as six translational operations.

The first pattern, which the researchers call narrating CellAg, relies on infographics, comic-style graphics, and interviews with chefs, employees, and chief executives to make complex science digestible. Young scientists in white suits work diligently in gleaming laboratories while founders offer personal testimony, vouching for the technology and its promise of a better world. Statistics and charts sit alongside images of suffering animals, blending economic motivation with ethical storytelling. The authors describe this as a translational act of guided explanation: it renders technical opacity trustworthy through controlled visual explanation and embodied spokespersons, while quietly narrowing the field of interpretation by foregrounding expertise, safety, and optimism and backgrounding uncertainty, conflict, and the difficulties of industrial scale-up.

The second pattern performs what the researchers call scalar translation, entangling the planetary, the microbial, and the domestic in rapid montage. Aerial tracking shots sweep over deforested land and monotonous agriculture before cutting to laboratory scenes; close-ups of petri dishes, test tubes, and microscopes give way to family barbecues and dinner tables; computer-generated cell biopsies are followed by sizzling pans. The laboratory becomes the hinge connecting the micro-scale of the cell to the scale of the planet, framing cell cultivation as a natural response to global crisis. Crucially, the authors note, the montage almost always skips the contested middle step: the upscaled fabrication plant, with its energy demands, infrastructure, and regulatory complexity. What the videos omit, they argue, is as persuasive as what they show.

A third pattern bundles crises together. Climate change, land scarcity, food security, animal welfare, water pollution, and even urban futures are condensed into a single narrative problem space to which cellular agriculture appears as a proportionate answer. One video in the corpus declares that by 2050 the world’s population will exceed ten billion and that cellular agriculture is here to tackle the resulting challenge. The researchers describe this as crisis–solution translation: diffuse collective anxieties are converted into a market-compatible horizon of action, positioning private firms as legitimate responders to anticipated catastrophe and framing investment and entrepreneurship as socially responsible rather than merely profit-seeking.

Perhaps the most striking pattern is temporal. Several videos invoke a nostalgic, pre-industrial past in which people grew their own food, knew the animals they ate, and lived in balance with nature, before contrasting that idyll with the devastation of industrial meat production. One company’s video, styled as a fairy-tale book turned by an invisible hand, moves from cows grazing in alpine meadows to the eroded landscapes of the Amazon, before asking whether technology could restore what has been lost. The researchers call this temporal translation: a promise to bridge an apparent contradiction by using technological progress to recover the virtues of an imagined past. The affective vocabulary of tradition is preserved, they argue, while the material basis of that tradition is replaced, allowing cultured meat to appear both radically novel and culturally continuous.

A fifth pattern moralises cleanliness. Sterile laboratories, spotless microscopes, and controlled interiors are repeatedly juxtaposed with barns, smoke, mud, and smoking chimneys, so that hygiene becomes shorthand for sustainability, safety, and ethical superiority. The researchers describe this hygienic translation as reframing food production as a problem of controlled environments and optimised processes, shifting attention away from questions of energy use, material throughput, and industrial dependency toward an ideal of transparent technical management. The messy materiality of animal agriculture is translated into a seemingly frictionless, governable environment, with the laboratory positioned as the clean successor to the farm.

The final pattern works through emotion. Videos individualise animals, giving them names and close-ups, and stage scenes of family barbecues rendered in nostalgic, 1970s-style footage. One company famously named a chicken Ian; another asks viewers whether cramming animals into barns is even natural. The researchers argue that this emotional translation redistributes responsibility: guilt is displaced onto existing production systems rather than consumption itself, so the viewer is not asked to give up meat but to accept it in a morally repaired form. Regret and compassion are converted into acceptance of technological substitution, legitimising a new production regime that promises ethical continuity without dietary rupture.

Taken together, the six patterns form what the authors call a repertoire rather than a typology, and they reveal a sector that, despite its fragmentation, presents a remarkably coherent audio-visual narrative about its own promise. The researchers are careful about what their findings do and do not show: the analysis does not demonstrate that cellular agriculture companies are already agents of a protein transition, only that their promotional media frame them as such in an effort to stabilise that position with consumers, investors, and regulators. By centring audio-visual material, the study extends scholarship on promissory narratives beyond text-based sources and raises pointed questions about how these translations travel, whether the meanings crafted in industry videos are reproduced, contested, or transformed in policy documents, news coverage, and audience reception. As cultured meat edges toward supermarket shelves, the study is a reminder that the battle for the future of protein is being fought not only in bioreactors, but in storyboards, scripts, and carefully edited frames.

Subject of Research: Promissory narratives and audio-visual storytelling in cellular agriculture promotional videos

Article Title: From lab to table: promissory narratives and the future of protein production in response to global crises

Article References: Müller, F. I., Meyer, F., & Miggelbrink, J. (2026). From lab to table: promissory narratives and the future of protein production in response to global crises. Geographica Helvetica, 81(3), 463-479. https://doi.org/10.5194/gh-81-463-2026

Image Credits: AI Generated

DOI: 10.5194/gh-81-463-2026

Keywords: cellular agriculture, cultured meat, promissory narratives, actor-network theory, socio-technical imaginaries, food systems, sustainability, multimodal analysis, alternative proteins, science communication, food media, Latour

The case for MuSCs rests on their intrinsic commitment to the myogenic lineage. Unlike pluripotent stem cells, which require elaborate and tightly controlled differentiation protocols before they reliably become muscle, or mesenchymal stromal cells, which convert into muscle fibers only with variable and often disappointing efficiency, MuSCs are already wired for the job. In living animals they are responsible for growth, repair, and regeneration of skeletal muscle, and when activated by environmental cues they proliferate, differentiate, and fuse into the multinucleated myofibers that give meat its characteristic texture. That lineage fidelity translates into straightforward induction conditions in the laboratory and a direct biological relevance to the tissue being reconstructed. Because MuSCs can be harvested directly from livestock skeletal muscle, the resulting cultured product begins its life with the same cellular identity as conventional meat, which is precisely what regulators and consumers will scrutinize.

The catch is that MuSCs, like other primary cells, are mortal in culture. During extended in vitro passage they undergo phenotypic drift and eventually replicative senescence, progressively losing both proliferative capacity and myogenic potential. For a commercial process that may require many population doublings to accumulate enough biomass, this finite lifespan is a fundamental constraint. The review emphasizes that performance also varies with species, breed, donor age and sex, and even the anatomical origin of the muscle from which the cells are isolated. One cited study found that MuSCs from Hanwoo steers proliferated faster and doubled more quickly than cells from Hanwoo cows, with distinct marker expression profiles and differentiation kinetics. The authors call for standardized reporting of population doubling time, proliferation rate, differentiation kinetics, and fusion efficiency so that results from different laboratories can be meaningfully compared and robust cell lines identified.

Understanding myogenesis at the molecular level is the second pillar of the roadmap. Myogenic regulatory factors, including MYF5, MYOD, myogenin, and MRF4, orchestrate the progression from quiescent stem cell to fused myotube, and their expression serves as the standard molecular readout of myogenic status. Growth factors modulate every step of this cascade: IGF-1 drives growth and protein synthesis, FGF-2 sustains the proliferation of bovine and porcine MuSCs while delaying premature differentiation, PDGF promotes myoblast expansion, HGF wakes quiescent cells, and TGF-beta participates in repair and matrix remodeling but can suppress myogenesis depending on context. Beyond the classic factors, immune-derived cytokines exert surprisingly powerful effects. Interleukin-6 significantly enhanced bovine satellite cell proliferation in serum-free media in one study, interleukin-15 promotes myosin heavy chain accumulation, and interleukin-4 drives the secondary fusion step that builds mature myofibers. Myokines such as decorin, which sequesters the muscle-growth inhibitor myostatin in the extracellular matrix, and irisin add further layers of regulation.

Myostatin itself emerges as one of the most promising molecular levers. A member of the TGF-beta superfamily, myostatin is a potent negative regulator of muscle growth, and its genetic disruption in mice and double-muscled cattle produces dramatic increases in muscle mass. In culture, inhibiting myostatin or its downstream SMAD2/3 signaling enhances MuSC differentiation, promotes myotube formation, and upregulates key myogenic markers. Notably, computational docking screens of natural product databases have identified food-relevant plant compounds, including licochalcone A and B, quercetin, and laxogenin, as candidate myostatin inhibitors, and subsequent experimental work showed that these compounds can enhance MuSC proliferation and differentiation or protect cells from oxidative stress. The review is careful to note that such in silico hits are hypothesis generators, not proven ingredients, and that most evidence still comes from rodent or cell-line models rather than primary livestock cells.

That caveat points to the field’s most stubborn bottleneck: the culture medium. Standard formulations rely on fetal bovine serum, an animal-derived cocktail that is expensive, compositionally variable from batch to batch, ethically fraught, and incompatible with a food product meant to reduce reliance on livestock. Serum-free and chemically defined media exist, and formulations such as Beefy-9 have supported sustained expansion of bovine satellite cells across multiple passages while preserving myogenicity, but optimal compositions are highly species- and stage-specific. Media must also be modulated across the process, with expansion formulations maintaining progenitor states and differentiation formulations triggering myotube formation. Economic analyses cited in the review estimate that culture media, particularly the recombinant growth factors used in serum-free systems, can account for roughly half or more of variable operating costs, making media design the decisive battleground for affordability.

This is where artificial intelligence enters the story. The review highlights Bayesian optimization approaches that have streamlined serum-free medium development for myoblasts, multi-objective AI designs that produced low-serum media with reduced cost and environmental impact, and machine learning frameworks that predict the quality and senescence state of porcine and Hanwoo muscle satellite cells from microscopy images alone. Computational screening of vast natural product libraries such as COCONUT, LOTUS, and ZINC can prioritize candidate bioactive compounds, growth factor substitutes, and even antibiotic alternatives before a single wet-lab experiment is run. The authors stress, however, that docking scores and predictions demand rigorous experimental validation of solubility, cytotoxicity, and effective concentrations in food-relevant cells, and that AI should be treated as a complement to, not a replacement for, experimental optimization.

Even with perfect cells and perfect media, meat is a three-dimensional structure, and recreating it is an engineering problem. Skeletal muscle is organized into hierarchical bundles of aligned myofibers wrapped in endomysium, perimysium, and epimysium, and its texture depends on fiber density, alignment, and the extracellular matrix proteins, chiefly collagens, laminins, and fibronectin, that scaffold the whole assembly. Scaffold research is shifting from generic tissue-engineering materials toward edible, food-grade options: soy protein porous scaffolds, whey protein isolate composites, zein-coated alginate fibers that align muscle cells, and decellularized mushroom-derived matrices that produced steak-like constructs with authentic texture. At production scale, anchorage-dependent MuSCs are grown on microcarriers in stirred-tank bioreactors, where recent work has demonstrated bovine satellite cell expansion at microcarrier concentrations up to 80 square centimeters per milliliter and transfer to 3-liter vessels, while edible soy protein microcarriers enabled a 24-fold expansion of bovine myoblasts in eight days followed by differentiation without any cell detachment step.

Safety, regulation, and environmental accounting complete the picture. Hazards span microbial contamination, residual antibiotics and reagents, genetic and phenotypic drift during prolonged culture, and the composition of any scaffold that remains in the final product, and the review argues for risk-based frameworks built on HACCP principles and good manufacturing practice rather than blanket rules. Regulatory pathways are already diverging, with Singapore treating cultured meat as a novel food requiring pre-market safety assessment while the US FDA and USDA share oversight. Life cycle assessments, meanwhile, show that environmental performance is exquisitely sensitive to energy sources, media purification, and production scale, meaning that generalized claims about cultured meat’s footprint should be treated with caution. The authors’ bottom line is that cultured meat will succeed only through integration: stable, well-characterized MuSC sources; defined, food-grade, affordable media; scalable bioprocesses; engineered tissue architecture; and AI-guided optimization, all tracked with quantitative benchmarks of productivity, differentiation efficiency, cost, and safety. The cells are willing. The challenge now is industrial.

Subject of Research: Muscle stem cell cultivation strategies and technical barriers for scalable cultured meat production

Article Title: MuSC cultivation for cultured meat production: recent advances, current limitations, and future directions

Article References: Lee, E. J., Ahmad, K., Shaikh, S., Lim, J. H., Ahmad, S. S., Seo, M. S., & Choi, I. (2026). MuSC cultivation for cultured meat production: recent advances, current limitations, and future directions. Food Science of Animal Resources, 46(1), Article 110. https://doi.org/10.1007/s44463-026-00108-2

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00108-2

Keywords: cultured meat, muscle stem cells, myogenesis, serum-free media, myostatin, scaffolds, bioreactors, microcarriers, artificial intelligence, food safety, life cycle assessment, bioprocess engineering

The motivation behind the work lies in one of the most pressing challenges of the coming decades. The world’s population, which surpassed 7.6 billion in 2018, is projected to reach 9.2 billion by 2050, and food demand is expected to rise by anywhere from 59 to 102 percent. Global meat consumption is anticipated to climb in parallel, reaching an estimated 4.55 million tons by 2050, with developing countries accounting for 56 percent of feed grain consumption. Against this backdrop, cultured meat, produced by cultivating livestock cells rather than slaughtering animals, has attracted intense interest as a way to conserve finite resources, address animal welfare concerns, and reduce the environmental footprint of protein production. Yet conventional cultured meat approaches, which rely on cells alone, have largely been limited to simple forms such as patties.

This is where 3D bioprinting enters the picture. By depositing cell-laden materials layer by layer, bioprinting can produce constructs in a wide variety of shapes that more closely mimic traditional meat products. It also allows researchers to optimize the cell growth environment, shortening production time, minimizing raw material use, and improving cost-effectiveness, while opening the door to customized meat tailored to individual dietary preferences or health needs. The critical enabling ingredient in this process is the bio-ink itself, typically built from materials such as alginate and gelatin, whose properties ultimately determine the quality of the final product. Gelatin, a degradation product of collagen, is prized for its excellent biocompatibility and its ability to support cell attachment, proliferation, growth, and differentiation, all of which are essential for natural and efficient tissue formation.

What has been missing, the authors argue, is a food-focused perspective. Most prior studies of gelatin-based bio-inks have been rooted in tissue engineering and biomedical applications, prioritizing biocompatibility and mechanical performance without adequately considering edibility, food-grade applicability, and source-dependent functionality within a food system. For cultured meat, bio-ink materials must simultaneously provide structural stability and printability while remaining suitable for consumption and scalable for food production. Systematic comparisons of edible animal-derived gelatin sources under standardized formulation conditions have been scarce, so the Korean team set out to fabricate bio-inks from bovine, porcine, and fish gelatin powders under unified conditions and to evaluate how source and concentration independently and interactively influence rheological behavior, printability, and structural properties.

The experimental design was straightforward but rigorous. Beef gelatin from Holstein cattle, pork gelatin from Landrace-Yorkshire-Duroc pigs, and fish gelatin from salmon, all with molecular weights ranging from roughly 10 to 100 kilodaltons depending on source, were dissolved in distilled water at concentrations of 4, 12, 20, 32, and 40 percent by weight at 45 degrees Celsius. Because gelatin-only formulations showed insufficient thermal stability at the 37 degrees Celsius incubation temperature used in cell culture, each gelatin solution was mixed 1:1 with a 6 percent sodium alginate solution, a supporting polymer that improves structural stability during printing and post-printing incubation. The blends were loaded into printing cartridges and stored at 4 degrees Celsius before testing. Printability trials used a Cellink BIO-X bioprinter with 27-gauge conical nozzles, a print bed held at 10 degrees Celsius, a print speed of 5 millimeters per second, and a pressure of 150 kilopascals, followed by ionic cross-linking in a 100 millimolar calcium chloride bath.

The results revealed systematic patterns across nearly every measured property. As gelatin concentration increased, pH decreased in all three sources, a trend the researchers attribute to the rising content of acidic amino acids such as aspartic and glutamic acid, which elevate hydrogen ion concentration as collagen breaks down into gelatin. Notably, fish gelatin samples consistently showed the highest pH values, a difference thought to reflect the vitamins, minerals, and amino acid profiles specific to each livestock species. Because higher pH levels are associated with increased metabolic activity in cells, the authors suggest that bio-inks with elevated pH may be particularly suitable as scaffold materials for cultured meat production. Color measurements told a complementary story: lightness declined with increasing gelatin concentration while redness and yellowness rose, and beef gelatin samples were significantly more yellow than the others, likely because bovine gelatin contains more lysine and other amino acids susceptible to the Maillard reaction, the non-enzymatic browning that occurs when the powder is dried in the presence of atmospheric oxygen.

Viscosity, arguably the most important rheological property for extrusion printing, showed the sharpest source-dependent differences. Initial viscosity increased with gelatin concentration in all formulations, but pork gelatin exhibited the highest values across every concentration tested. The explanation lies in molecular architecture: pork gelatin possesses greater structural integrity of its beta and gamma chains, creating physical entanglements that impede polymer flow, whereas fish gelatin has a looser structure with weaker intermolecular bonds and lower levels of proline and hydroxyproline, the amino acids that govern gelation and melting point, making it heat-sensitive and unable to build high viscosity even at elevated concentrations. Intriguingly, the most concentrated pork gelatin formulations, at 32 and 40 percent, showed viscosity that declined over time, apparently because excessive intermolecular interactions at very high concentrations prevent the formation of a stable gel network and increase internal stress. This observation led the team to recommend keeping porcine gelatin below 32 percent when manufacturing bio-ink.

Printability tests drove the study’s central conclusion home. At 4 percent, all three gelatin types extruded as a liquid with no visible lattice formation whatsoever. Beef and fish gelatin at 12 and 20 percent could be extruded but collapsed rapidly, retaining lattice structures only up to 0.3 centimeters in height. Pork gelatin, by contrast, formed partial lattices at 12 and 20 percent and was the only formulation to maintain scaffold integrity up to 0.5 centimeters. At 32 and 40 percent, pork gelatin became so solidified that it could not be extruded at all, a consequence of hydrogen bonding and van der Waals forces increasing the material’s elastic restoring force until it behaved more like a solid than a printable viscoelastic fluid. The richer proline and hydroxyproline content of porcine gelatin appears to foster stronger hydrogen bonding and a more stable three-dimensional network, providing the internal binding strength needed to resist gravitational collapse after deposition.

Structural analysis and statistical correlation rounded out the picture. Under the microscope, pork gelatin scaffolds displayed rougher surfaces than the other sources, a feature that may actually benefit cultured meat production by increasing surface irregularities and contact area for cell attachment. The 20 percent pork gelatin sample showed significantly higher grid size and gel strength than all other formulations, a combination the researchers highlight as a favorable balance: larger grid sizes facilitate nutrient diffusion and material exchange within the printed structure, while greater gel strength preserves scaffold integrity during handling and culture. Pearson correlation analysis quantified these relationships, revealing a strong positive correlation between gel strength and viscosity with a coefficient of 0.88, and between grid size and gel strength with a coefficient of 0.89. Even color proved tightly linked, with redness and yellowness showing a near-perfect correlation of 0.99, suggesting that bio-ink color tone can be controlled predictably, an attribute the authors note matters for the appearance quality control of commercial cultured meat.

Taken together, the findings offer a practical recipe for the emerging cultured meat industry: choose pork gelatin, keep the concentration near 20 percent, and pair it with alginate for thermal stability. The work also underscores a broader lesson in biomaterials science, that seemingly minor differences in molecular composition, down to the amino acid content of a protein extracted from a particular animal’s skin, can cascade into dramatic differences in how a material flows, gels, and holds its shape under a printing nozzle. As the demand for alternative proteins accelerates, studies like this one, which treat food-grade applicability as seriously as mechanical performance, will help determine whether 3D-printed cultured meat can move from laboratory demonstration to dinner plate.

Subject of Research: Physicochemical and printability properties of animal-derived gelatin bio-inks for 3D-printed cultured meat scaffolds

Article Title: Physicochemical properties of 3D bio-ink prepared with beef, pork, and fish gelatin

Article References: Kang, K.-M., Lee, S.-H., & Kim, H.-Y. (2026). Physicochemical properties of 3D bio-ink prepared with beef, pork, and fish gelatin. Food Science of Animal Resources, 46(1), Article 66. https://doi.org/10.1007/s44463-026-00071-y

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00071-y

Keywords: gelatin, bio-ink, 3D bioprinting, cultured meat, pork gelatin, printability, viscosity, gel strength, scaffolds, sodium alginate, food science, collagen

The study, published in Applied Microbiology and Biotechnology, set out to answer a question that has been asked repeatedly in the cultured meat community but seldom resolved with such systematic rigor: can sera from adult cattle, pigs, and chickens, collected as a byproduct of ordinary meat processing, support the demanding growth requirements of muscle cells destined for cultured meat? The answer, according to the research led by Da-Young Lee and corresponding author Sun Jin Hur, is a qualified but emphatic yes, provided the sera are carefully characterized and supplemented.

The investigators began by collecting blood from cattle, pigs, and chickens under protocols approved by the Animal Experiment Ethics Committee of Chung-Ang University, with approvals numbered 202401030030 and 202301020084. All animal procedures were conducted in accordance with relevant institutional and national guidelines. Because livestock serum would be derived from animals already processed for food, the approach sidesteps the most persistent ethical objection to FBS, namely its fetal origin, while also promising a supply chain that is more abundant, more traceable, and potentially far cheaper than the fetal serum market.

The first stage of the work involved comprehensive biochemical and physicochemical profiling of the sera. The researchers measured parameters that matter deeply to cell biologists: osmolality, pH, protein content, and the biochemical composition that determines whether a serum can sustain living cells. All of the livestock sera tested met sterility requirements, a crucial threshold for any candidate medium component destined for food production. Notably, however, some of the livestock sera showed deviations in physicochemical parameters relative to FBS, deviations that would later inform the optimization strategy. This finding matters because serum is not a simple solution but a complex biological cocktail of growth factors, hormones, attachment factors, carrier proteins, and lipids, and even modest differences in composition can ripple through cell behavior in culture.

With the sera characterized, the team turned to the functional heart of the study: proliferation and differentiation assays using bovine satellite cells, the muscle stem cells responsible for postnatal muscle growth and regeneration. These cells are the workhorses of cultured meat, because they are the ones that must divide vigorously to build biomass and then differentiate and fuse into the multinucleated muscle fibers that give meat its texture and protein content. The results were strikingly species-dependent. Bovine and porcine sera consistently supported robust proliferation, myogenic differentiation, and long-term expansion of the satellite cells. Chicken serum, by contrast, failed to deliver the same performance, unable to sustain the growth trajectory that bovine and porcine sera achieved. For a field that has mostly treated serum as interchangeable, this species-specific divergence is a meaningful data point, suggesting that donor species compatibility should be a central design criterion in serum substitution.

Perhaps the most demanding test was long-term serial passaging. In industrial cultured meat bioprocessing, cells cannot simply be grown once and harvested; they must be expanded repeatedly, through many rounds of passaging, to generate the enormous cell numbers required to fill bioreactors at commercial scale. Serum that supports a few days of growth is of limited value if the cells senesce or lose their myogenic potential after several passages. The optimized bovine- and porcine-based substitutes supported stable proliferation during serial passaging, indicating that the cells retained their proliferative capacity and functional identity over extended culture. This stability is precisely the property that distinguishes a laboratory curiosity from a scalable industrial input.

The optimization itself represents the technical centerpiece of the work. Raw livestock serum, while competent, did not fully match FBS in every respect, so the researchers enhanced the final formulations with targeted supplements. Two additives proved particularly effective: lipid-rich albumin and insulin-transferrin-selenium, the latter supplied at a concentration of 25 micrograms per milliliter. The logic of these supplements is grounded in cell physiology. Albumin serves as a carrier protein for fatty acids and other lipids, which muscle cells require in substantial quantities for membrane synthesis and energy metabolism but which adult serum can deliver inconsistently. Insulin provides anabolic signaling that drives glucose and amino acid uptake, transferrin supplies iron in a controlled and bioavailable form, and selenium acts as an antioxidant cofactor that protects cells from oxidative stress during rapid proliferation. Together, these supplements significantly enhanced cellular performance, closing the gap between livestock serum and FBS to the point of full functional replacement.

The economic implications may prove as consequential as the biological ones. Fetal bovine serum is one of the most expensive components of cell culture medium, with prices driven by limited supply, batch-to-batch variability, and demand from pharmaceutical and research markets that far exceed anything the cultured meat industry can command. Cost analysis conducted by the Chung-Ang University team revealed that replacing FBS with the optimized livestock-derived serum formulations reduced total medium cost by 62.6 percent. Given that medium costs are widely regarded as the single largest barrier to price parity between cultured meat and conventional meat, a reduction of this magnitude in a core medium ingredient represents a substantial step toward commercial viability. The fact that the raw material, adult livestock serum, is an abundant byproduct of existing slaughter operations adds a circular economy dimension, transforming a low-value waste stream into a high-value input.

The study does not claim that every obstacle has been cleared. The researchers note that while all sera met sterility requirements, the deviations in physicochemical parameters among some livestock sera underscore the need for standardization, since cultured meat production at scale will demand consistent, reproducible serum quality from batch to batch. The poor performance of chicken serum also illustrates that a single universal substitute may not exist, and that serum selection may need to be matched to cell line and process. Regulatory pathways for food-grade serum of slaughter origin will likewise require attention as the technology moves toward commercial deployment. Nevertheless, the demonstration that bovine and porcine sera can fully replace FBS, sustain serial passaging, and do so at dramatically reduced cost addresses the three most cited weaknesses of FBS at once: ethics, scalability, and price.

Funded through the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry via the High Value-added Food Technology Development Program under the Ministry of Agriculture, Food and Rural Affairs, the work reflects a growing national commitment to cell-based food technology. For an industry that has struggled to reconcile its sustainability narrative with its dependence on fetal calf blood, optimized slaughter livestock serum offers a resolution that is effective, scalable, and ethically aligned. If subsequent scale-up studies confirm these results in suspension culture and bioreactor settings, the humble byproduct of the slaughterhouse floor may become one of the key ingredients that finally allows cultured meat to grow up.

Subject of Research: Optimization of slaughter livestock serum as a fetal bovine serum substitute for bovine satellite cell culture in cultured meat production

Article Title: Optimization of slaughter livestock serum as an alternative to fetal bovine serum in cultured meat application

Article References: Lee, D.-Y., Mariano, E., Park, J. W., Namkung, S., Choi, S. Y., Lee, W. J., Shin, Y. W., Bok, C. H., & Hur, S. J. (2026). Optimization of slaughter livestock serum as an alternative to fetal bovine serum in cultured meat application. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-14017-3

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14017-3

Keywords: cultured meat, fetal bovine serum, livestock serum, cell culture, bovine satellite cells, myogenic differentiation, serum substitutes, bioprocessing, cell proliferation, medium cost reduction, food biotechnology, sustainable food production

The authors begin with the supply side. Serum albumin is the most abundant protein in blood plasma, and slaughterhouse blood represents a massive, cheap and largely untapped reservoir of it. Plasma fractionation, a technology refined since the landmark Cohn fractionation work of the 1940s, allows albumin to be separated from other plasma proteins at industrial scale. In medicine, serum albumin is indispensable: it maintains osmotic pressure in the bloodstream, ferries fatty acids, hormones, drugs and metabolites through the circulation, and serves as a biomarker for liver function and inflammation. Recombinant DNA technology now permits production of human serum albumin in yeast and other expression systems, easing supply constraints for pharmaceutical use. But while the biomedical community has thoroughly industrialized the protein, the food industry has been far more hesitant, and the review asks why.

Part of the answer lies in the protein’s remarkable structure. Serum albumin is a single polypeptide chain of roughly 585 amino acids folded into a heart-shaped, three-domain architecture held together by disulfide bridges. This topology gives the protein its famous promiscuity: it possesses multiple hydrophobic pockets that can bind an astonishing range of small molecules. In food systems, that means albumin can sequester and carry bioactive compounds that would otherwise degrade or taste bitter. Studies reviewed by the authors show that bovine serum albumin binds polyphenols such as resveratrol, curcumin, genistein and tea catechins; food colorants like indigo carmine; preservatives such as sodium benzoate and sodium propionate; and flavor compounds including maltol. Each of these interactions has been mapped with spectroscopy, calorimetry and molecular docking, and each suggests a practical application: albumin could act as a natural carrier that protects delicate antioxidants through processing and delivery, then releases them in the gut.

The review’s survey of functional applications begins with emulsions, arguably the most mature arena for albumin in food research. As early as the 1980s, scientists demonstrated that bovine serum albumin is an effective emulsifier, rapidly adsorbing at oil-water interfaces and unfolding to form stabilizing films. Recent work has pushed the concept much further. Albumin stabilized fish oil-in-water emulsions, protecting oxidation-prone omega-3 lipids; it formed soft protein particles when glycated, capable of stabilizing high internal phase emulsions that resemble solid gels while containing mostly oil; and conjugates of albumin with maltodextrin or green tea polysaccharides showed improved emulsifying and antioxidant performance. Ultrasonically engineered albumin nanoparticles have recently been used to build ultra-stable Pickering emulsions, in which solid protein particles cling to droplet surfaces like microscopic armor. In these systems, albumin is not merely a model; it performs on par with the dairy and plant proteins that dominate commercial emulsifier markets.

Foams represent a second frontier, and one where albumin’s properties are particularly striking. Proteins stabilize foams by migrating to air-water interfaces and forming elastic films that resist coalescence, and albumin excels at this. Recent structural work using human serum albumin has revealed, at near-atomic resolution, how the protein reorganizes when it reaches a foam surface, insights that explain its exceptional surface activity. Studies reviewed in the paper show albumin-based nanofibrils with strong emulsifying and foaming activity, and complexes of bovine serum albumin with chitooligosaccharides that have been tested directly in angel food cake, one of the most foam-dependent products in the bakery repertoire. That a blood-derived protein can improve the texture of a familiar dessert illustrates how far the technology has moved beyond abstract model systems.

The review then turns to delivery architectures: nanoparticles and hydrogels. Albumin self-assembles into nanoscale particles under pH-driven, ultrasonic or desolvation methods, and food scientists have loaded these particles with curcumin and resveratrol together, with green tea catechins, or with extracts of Lycium barbarum leaves, consistently reporting enhanced protection and bioavailability of the cargo. Hydrogels formed from albumin, whether through heat-induced aggregation, pH manipulation or the formation of amyloid-like fibrils, offer soft, biocompatible matrices that can encapsulate vitamins and other labile nutrients and release them in a controlled fashion. Additive manufacturing studies have even shown that albumin-based hydrogels and bioplastics can be 3D printed, hinting at personalized nutrition applications in which nutrient-loaded protein scaffolds are printed directly into foods. These systems borrow heavily from the biomedical literature, where albumin hydrogels and nanoparticles are already advanced drug-delivery platforms, and the review makes the case that the food field should keep borrowing.

Perhaps the most topical section of the review concerns cultured meat. Cell-cultivated meat production currently depends heavily on fetal bovine serum, a costly, ethically fraught and poorly defined supplement used to grow muscle cells in bioreactors. Serum albumin is one of the principal functional components of that serum, providing growth factors a stable carrier, buffering capacity and osmotic support. The Chung-Ang University group has itself published studies showing that livestock blood can be processed into fetal bovine serum substitutes and that egg-derived extracts may replace serum components, and other teams have demonstrated serum-free media for bovine satellite cells and fish myoblasts, as well as recombinant albumin produced in Pichia pastoris for serum-free culture. In this context, albumin is not a niche ingredient but a central node in the effort to make cultivated meat affordable, scalable and free of animal-derived serum, one of the biggest bottlenecks facing the entire industry.

So why, despite all this capability, is serum albumin still mainly a model protein in food science rather than a listed ingredient? The review identifies a cluster of consumer-facing barriers. Cultural acceptance is foremost: blood has deep culinary roots in some traditions, from black pudding to blood soups, but in many Western markets the idea of blood-derived ingredients triggers disgust responses that no technical performance can easily overcome. Religious dietary laws, including halal and kosher requirements, impose strict constraints on blood and blood derivatives, effectively excluding the ingredient from entire markets. Dietary trends amplify the problem: the rapid growth of plant-based and vegetarian eating patterns means a growing share of consumers actively avoid animal-sourced proteins, however functional they may be. Then there is allergenicity. Serum albumins are unusual allergens, highly cross-reactive across mammalian species, meaning that a consumer sensitized to, say, cat or dog dander albumin may react to bovine serum albumin in food. Milk and meat products already contain trace albumins that can trigger reactions in sensitive individuals, and adding concentrated albumin to processed foods would raise genuine safety and labeling questions.

The authors do not present these obstacles as a verdict; they present them as an agenda. The review’s forward-looking sections point toward strategies that could defuse each barrier: recombinant and precision-fermentation routes to albumin that decouple the protein from blood; careful processing and formulation that reduce allergenic potential; transparent labeling and consumer research to understand where blood-derived, fermentation-derived and hybrid ingredients might be accepted; and targeted applications where albumin’s unique binding and interfacial properties deliver value that commodity proteins cannot, such as protecting expensive nutraceuticals or enabling serum-free cultured meat media. In a circular economy framing, valorizing slaughterhouse blood also addresses a genuine sustainability problem, converting a waste stream with a heavy environmental footprint into high-value protein.

The broader message of the review is a lesson about how ingredients actually reach our plates. Serum albumin has spent half a century proving itself in emulsions, foams, gels, nanoparticles and cell culture, accumulating an impressive technical dossier along the way. What has been missing is not science but systems thinking: the economics of extraction, the regulations governing novel foods, the allergies and taboos of consumers, and the competitive price of soy, whey and egg proteins. As the food industry races to feed a growing population with less waste, fewer animals and cleaner labels, proteins like serum albumin, sitting unnoticed in an undervalued by-product, may find their moment. The science, as this review makes abundantly clear, has been ready for some time. The remaining challenge is persuading eaters, regulators and manufacturers to take a second look at what flows down the slaughterhouse drain.

Subject of Research: Serum albumin as a functional protein ingredient in food technologies

Article Title: Serum albumin in food technologies: current applications and future perspectives

Article References: Venter, C., Mariano, E., Lee, D.-Y., & Hur, S. J. (2026). Serum albumin in food technologies: current applications and future perspectives. Food Science and Biotechnology. https://doi.org/10.1007/s10068-026-02305-7

Image Credits: AI Generated

DOI: 10.1007/s10068-026-02305-7

Keywords: serum albumin, emulsions, foams, nanoparticles, hydrogels, cultured meat, slaughterhouse blood, ligand binding, allergenicity, Pickering emulsions, food by-products, serum-free media

The urgency behind the research is easy to grasp. The United Nations projects a global population of roughly 9.8 billion by 2050, and the Food and Agriculture Organization estimates that 70 percent more food will be needed to feed it. Meat demand is rising fastest in developing economies, where growing incomes translate into appetite for premium animal products. According to the OECD and FAO, world meat output reached an estimated 365 to 373 million tons in 2024 and could exceed 400 million tons by 2034, with Asia driving much of the increase. Conventional livestock farming already accounts for about 14.5 percent of global greenhouse gas emissions, 29 percent of agricultural freshwater use, and 40 percent of land utilization, which makes the search for alternatives increasingly pressing.

Technically, cultured meat production rests on three pillars: sourcing and expanding the right cells, growing them at scale in bioreactors, and structuring the resulting tissue into something that resembles real meat. The review traces the cell biology in detail. Satellite cells, the muscle stem cells first identified by Alexander Mauro in 1961, readily differentiate into myotubes and remain a favored starting material. Embryonic stem cells from pigs and cattle are still difficult to maintain in an undifferentiated state, but induced pluripotent stem cells, or iPSCs, offer an ethically cleaner and more scalable route, since adult cells can be reprogrammed to a pluripotent state and then directed to become muscle or fat. Immortalized cell lines, which replicate indefinitely in culture, are also under investigation as a way to avoid repeated animal biopsies.

Scaling up is where the engineering gets hard. Conventional stirred-tank bioreactors, the workhorses of pharmaceutical cell culture, struggle with cost, energy demand, and shear stress when adapted to meat production. Microcarrier-based expansion, in which adherent muscle and fat cells grow on tiny suspended particles, has emerged as a promising strategy because it dramatically increases the surface area available for cell attachment. But microcarriers bring their own problems: uneven cell distribution, particle aggregation, mass-transfer limits, and the challenge of separating cells from carriers. The review highlights edible and biodegradable microcarriers as a critical innovation, citing recent work on macroporous edible carriers used to 3D-print cultured fish fillets. Perfusion, packed-bed, and hollow-fiber bioreactor designs are also being explored, each trading off nutrient delivery, shear, and scalability in different ways.

Scaffolding technology, the third pillar, determines whether cultured meat can ever match the texture of a steak. An effective scaffold must mimic the mechanical and biochemical properties of native muscle while remaining edible, cheap, and food-safe. Collagen and gelatin have long been the materials of choice, but their animal-derived origins raise sustainability concerns, pushing researchers toward plant, algal, fungal, and marine alternatives, including proteins recovered from fish-processing by-products. The review emphasizes that scaffold stiffness and viscoelasticity directly regulate myoblast behavior, so tuning stress relaxation and elasticity is now a central design goal. Hydrogels, bioinks, and decellularized plant tissues are among the most promising platforms, and crosslinking strategies, from thermal gelation to enzymatic methods, are being refined to keep scaffolds stable under dynamic culture conditions.

On the environmental question, the review refuses to declare a winner. The landmark 2011 life cycle assessment by Tuomisto and Teixeira de Mattos found that cultured meat could use 7 to 45 percent less energy, emit 78 to 96 percent fewer greenhouse gases, require 99 percent less land, and consume 82 to 96 percent less water than European-produced meat. Those figures have been cited endlessly, but the new review urges caution. Anticipatory life cycle assessments are scenarios, not predictions, and future production methods may differ fundamentally from the models. More strikingly, a cradle-to-gate assessment by Risner and colleagues found that cultured meat produced with highly refined growth media could have a greater environmental impact than conventional beef, because the pharmaceutical-grade ingredients are so energy-intensive to make.

The climate accounting is subtler than it first appears. Lynch and Pierrehumbert showed that because cattle emit methane, a potent but short-lived greenhouse gas, their warming effect can peak and stabilize, whereas cultured meat production releases carbon dioxide, which persists in the atmosphere for centuries. Over long time horizons, the persistent CO2 from cell-culture facilities could outweigh the avoided methane, particularly in scenarios with modest meat consumption. Energy demand is a recurring theme: producing a kilogram of beef, pork, or sheep requires roughly 27,410, 16,300, and 23,100 megajoules respectively, while cultured meat is estimated at 32,710 megajoules, even though it needs the least land. Improving energy efficiency, the authors conclude, will be essential to realizing any environmental benefit.

Economics may be the toughest barrier of all. Culturing animal cells demands precise temperature, pH, and oxygen control, continuous electricity, and expensive growth media, with growth factors and serum alternatives accounting for a large share of total cost. Fetal bovine serum, long the standard supplement, is being replaced in research labs but not yet at industrial scale. Until production costs fall substantially, cultured meat remains financially inaccessible to most consumers, especially in low- and middle-income countries where meat demand is growing fastest. The review also notes that cultured meat competes not only with conventional meat but with plant-based alternatives that are already widely accepted, cheaper, and on supermarket shelves.

Consumer psychology adds another layer of complexity. Surveys suggest likely early adopters tend to be young, well-educated meat eaters who are open to reducing their consumption of slaughtered meat, but food neophobia and perceptions of unnaturalness remain powerful deterrents, particularly in parts of Asia. Even the name matters: labels like in vitro meat, clean meat, lab-grown meat, and cultured meat each shape public perception differently, and advocates worry that any term implying the product is fake could undermine acceptance. Sensory fidelity is a related challenge, since cultured tissue lacks the blood vessels, nerves, intramuscular fat, and connective tissue that contribute so much to the flavor of conventional beef.

Ethically, the picture is genuinely mixed. Cultured meat would spare billions of animals the confinement and slaughter of factory farming, and some scientists even classify it as a vegetarian product, an appealing prospect for vegans and conscientious omnivores. Yet cells must still be harvested from living animals by biopsy, raising welfare questions of its own, and the continued reliance on animal-derived materials in media and scaffolds complicates the slaughter-free narrative. The review closes with a call for serum-free media, energy-efficient bioreactors, vascularized tissue engineering, real-world life cycle data, transparent labeling, and clear regulatory frameworks, arguing that only sustained interdisciplinary collaboration among biotechnologists, food scientists, policymakers, and industry will determine whether cultured meat becomes a transformative food system technology or an expensive niche experiment.

Subject of Research: Environmental, technological, and socio-economic assessment of cultured meat as an alternative to conventional livestock production

Article Title: A review of environmental, technological, and socio-economic aspects of cultured meat

Article References: Singh, R., Prasad, S., Younis, K., & Yousuf, O. (2026). A review of environmental, technological, and socio-economic aspects of cultured meat. Discover Biotechnology, 3(1), Article 5. https://doi.org/10.1007/s44340-026-00052-3

Image Credits: AI Generated

DOI: 10.1007/s44340-026-00052-3

Keywords: cultured meat, cellular agriculture, food security, sustainability, tissue engineering, bioreactors, greenhouse gas emissions, animal welfare, consumer acceptance, life cycle assessment, stem cells, food technology